Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


A back-up plan

Nature (2019)

Nature (2019)

Ferroptosis is a form of iron-dependent cell death caused by elevated lipid peroxidation. Glutathione peroxidase 4 (GPX4)-mediated conversion of phospholipid hydroperoxides into non-toxic lipid alcohols is thought to mitigate ferroptosis, and GPX4 inhibitors promote ferroptosis in certain cancer cells. To explore alternative mechanisms to prevent ferroptosis, Besuker et al. performed a synthetic lethal CRISPR–Cas screen in a ferroptosis-resistant cell line, and Doll et al. screened for genes that could complement GPX4 inhibition. In both cases, they revealed that an NADH-dependent coenzyme Q oxidoreductase, ferroptosis-suppressor protein 1 (FSP1), protected cells against ferroptosis. FSP1 required N-myristoylation and plasma-membrane association for its antiferroptotic activity, and it reduced coenzyme Q10 in the lipid bilayer to (re)generate radical-trapping antioxidants that inhibit lipid peroxidation. The increased expression of FSP1 was correlated with ferroptosis resistance in numerous cancer cell lines, and inhibition of FSP1 resulted in increased sensitivity to ferroptosis inducers. Altogether, these findings reveal a parallel pathway that mitigates ferroptosis together with GPX4.

Author information



Corresponding author

Correspondence to Grant Miura.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Miura, G. A back-up plan. Nat Chem Biol 15, 1131 (2019).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing